{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16682722",
  "DateCompleted": {
    "Year": "2006",
    "Month": "07",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2007",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2006",
        "Month": "05",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1527-7755",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "19",
        "PubDate": {
          "Year": "2006",
          "Month": "Jul",
          "Day": "01"
        }
      },
      "Title": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
      "ISOAbbreviation": "J Clin Oncol"
    },
    "ArticleTitle": "When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?",
    "Pagination": {
      "StartPage": "2975",
      "EndPage": "2977",
      "MedlinePgn": "2975-7"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Adams",
        "ForeName": "Jared R",
        "Initials": "JR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Angelotta",
        "ForeName": "Cara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bennett",
        "ForeName": "Charles L",
        "Initials": "CL"
      }
    ],
    "PublicationTypeList": [
      "Comment",
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Clin Oncol",
    "NlmUniqueID": "8309333",
    "ISSNLinking": "0732-183X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "143011-72-7",
      "NameOfSubstance": "Granulocyte Colony-Stimulating Factor"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Clin Oncol. 2006 Jul 1;24(19):3187-205",
      "PMID": "16682719"
    },
    {
      "RefSource": "J Clin Oncol. 2006 Jul 1;24(19):2991-7",
      "PMID": "16682725"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cost-Benefit Analysis"
    },
    {
      "QualifierName": [
        "chemically induced",
        "economics",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "economics",
        "therapeutic use"
      ],
      "DescriptorName": "Granulocyte Colony-Stimulating Factor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemically induced",
        "economics",
        "prevention & control"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}